EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

The reduction of P-glycoprotein expression by small interfering RNAs is improved in exponentially growing cells



The reduction of P-glycoprotein expression by small interfering RNAs is improved in exponentially growing cells



Oligonucleotides 14(3): 191-198



Small interfering RNAs (siRNAs) are powerful tools in specifically silencing gene expression. Nevertheless, their efficiency can be limited when targeting proteins with an unusually long half-life, such as P-glycoprotein (P-gp), which is involved in the multidrug resistance phenomenon. P-gp is characterized by a long half-life, which may vary depending on the cell line and, for some of them, on serum deprivation or high cell density. In the present paper, involvement of an exponential cell growth phase in the improvement of siRNA efficiency has been suggested. The doxorubicin-selected human line MCF7-R was shown to be a more adapted model than NIH-MDR-G185 cells stably transfected with human mdr1. Nonspecific effects occurring at moderate (100 nM) siRNA concentration have been shown. Two efficient siRNAs led to a very satisfactory P-gp extinction (only 20% P-gp expression remaining) with siRNA concentration as low as 20 nM.

(PDF emailed within 0-6 h: $19.90)

Accession: 050710352

Download citation: RISBibTeXText

PMID: 15625914

DOI: 10.1089/oli.2004.14.191



Related references

The reduction of P-glycoprotein expression by small interfering RNAs is improved in exponentially growing cells. Oligonucleotides 104(3): 191-198, 2004

Small interfering RNAs for reversion of MDR1/P-glycoprotein-mediated multidrug resistance in cancer cells. 2007

Silencing of gene expression in cultured cells using small interfering RNAs. Current Protocols in Cell Biology Chapter 27: Unit 27.1.1-28, 2010

Suppressing the expression of keratoepithelin in cultured cells by small interfering rnas. ARVO Annual Meeting Abstract Search & Program Planner : Abstract No 3850, 2003

Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nature Biotechnology 20(5): 500-505, 2002

Transfer and Expression of Small Interfering RNAs in Mammalian Cells Using Lentiviral Vectors. Acta Naturae 5(2): 7-18, 2013

Treatment of HeLa cells with small interfering RNAs against HuR or Lamin A and C results in cyclooxygenase-2 expression. European Cytokine Network 14(Supplement 3): 39, Sept, 2003

Inhibition of chTERT mRNA expression in MDCC-MSB1 cells by small interfering RNAs. 2008

Effects of small interfering RNAs targeting Fascin on gene expression in oral cancer cells. Journal of Oral Pathology & Medicine 38(9): 722-730, 2009

Modulation of MDR1 gene expression in multidrug resistant MCF7 cells by low concentrations of small interfering RNAs. Biochemical Pharmacology 70(10): 1424-1430, 2005

Selective silencing of viral gene E6 and E7 expression in HPV-positive human cervical carcinoma cells using small interfering RNAs. Methods in Molecular Biology 292: 401-420, 2004

Improved silencing properties using small internally segmented interfering RNAs. Nucleic Acids Research 35(17): 5886-5897, 2007

Synthetic small interfering RNAs reduce bcr-abl gene expression in leukaemic cells of de novo Philadelphia(+) acute myeloid leukaemia. Clinical and Experimental Medicine 6(1): 45-47, 2006

Effects of small interfering RNAs targeting MAPK1 on gene expression profile in HeLa cells as revealed by microarray analysis. Cell Biology International 32(9): 1081-1090, 2008

RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America 99(9): 6047-6052, 2002